Clarify the Role of Veozah for Hot Flashes

July 2023

Veozah (fezolinetant) will be a new nonhormonal med for managing moderate to severe hot flashes during menopause.

It’s the first neurokinin 3 antagonist. It blocks neurokinin B, a chemical that regulates temperature...decreasing vasomotor symptoms.

Tell patients to expect a benefit of about 2 or 3 fewer hot flashes per day with Veozah 45 mg po once daily compared to placebo.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote